BMI	Body mass index
WHO	World Health Organization
BC	Breast cancer
EBC	Early breast cancer
HR+	Hormone receptor-positive
NCCN	National Comprehensive Cancer Network
MBC	Metastatic breast cancer
HER2−	Human epidermal growth factor receptor 2–negative
FISH	Fluorescence in situ hybridization
ISH	In situ hybridization
ORR	Objective response rate
CBR	Clinical benefit rate
CR	Complete response
PR	Partial response
SD	Stable disease
RECIST	Response Evaluation Criteria in Solid Tumors
CT	Computed tomography
HR	Hazard ratio
CI	Confidence interval
OR	Odds ratio
AI	Aromatase inhibitor
TME	Tumor microenvironment
PPAR-γ	Peroxisome proliferator-activated receptor γ
CAAs	Cancer-associated adipocytes
CAAT	Cancer-associated adipose tissue
IGFBP2	Insulin-like growth factor binding protein 2
VAT	Visceral adipose tissue